Haisco(SZ:002653) Zhong Guo Jing Ji Wang·2025-11-17 07:52Core Viewpoint - The announcement from Haishike (002653.SZ) reveals the completion of a share reduction plan by a significant shareholder, indicating a strategic move in the company's equity structure and potential implications for investor sentiment [1][2]. Share Reduction Details - The significant shareholder, Shen Ping, reduced her holdings by a total of 10,373,400 shares, which represents 0.926% of the company's total share capital [1][2]. - The reduction occurred between September 1, 2025, and November 14, 2025, with share prices ranging from 50.00 to 59.83 yuan, and an average selling price of 54.202 yuan per share [1][2]. - The total cash generated from this reduction amounted to approximately 562 million yuan [1]. Shareholder Background - Shen Ping, the spouse of the controlling shareholder Wang Junmin, initially held 20.9 million shares, accounting for 1.93% of the total share capital [3]. - Since March 14, 2023, Shen Ping has cumulatively reduced her holdings by 15,371,100 shares, realizing approximately 418 million yuan in cash [3][4]. Fundraising Activities - Haishike is planning to issue A-shares to specific investors, aiming to raise up to 1.245 billion yuan, which will be allocated for new drug research and to supplement working capital [2][3]. - The number of shares to be issued will not exceed 70 million, with CITIC Securities acting as the lead underwriter [2].